The Team We’re a lot like a jigsaw here at WhatClinic.com. So, when you make a jigsaw you take each new piece, turn it round or upside down and figure out where it fits. But when you get down to serious business and piece those bits all together in just the right way … everything clicks. And you get to be part of something greater than the sum of its parts. The WhatClinic.com jigsaw is growing. Are you our missing piece?
Management Dave Roe, Chief Executive Officer
As CEO of WhatClinic, David balances hands-on leadership with a strategic vision for the company’s future. He is deeply involved in both day-to-day operations and long-term planning, ensuring WhatClinic continues to grow and evolve in an ever-changing market. A trusted mentor to his team, David fosters a culture of collaboration, innovation, and continuous improvement.
Before joining WhatClinic, David held senior leadership roles at AOL, where he managed global web applications across Search, Retail Shopping, and Financial Products - overseeing product lines that generated billions in revenue. He also served as a Project Manager at Accuris (TE Software).
David holds an honors degree in Computer Science from Trinity College. Outside of work, he enjoys gardening and has an enduring addiction to board games.
Conor Leech, Chief Revenue Officer
Conor has been leading the customer service, renewal, and new business sales teams since 2010. Under his leadership, WhatClinic successfully transitioned from a subscription-based model to a pay-per-lead model and expanded into over 50 markets worldwide. As CRO, Conor oversees the sales and marketing strategy, working closely with new and existing customers to ensure they receive maximum ROI. His focus is on driving growth and delivering value to clinics around the globe.
Before joining WhatClinic and returning to Ireland, Conor held international sales roles at The Wall Street Journal and Reed Business Information Systems in Brussels and London.
Outside of work, he enjoys sailing, golf, and coaching his son's rugby team.
Marta Strzelecka, Chief Product Officer
Joining WhatClinic in 2008 as a Junior Product Manager, Marta has grown through various roles - including Business Analyst and Product Owner - before stepping into the CPO position. Focused on delivering maximum value, she is passionate about building products that make a real impact. She believes in getting things done and values the dedication and efforts of those she works with.
She holds an MSc in International Business from Poznań University of Economics and Business, bringing a strong analytical mindset and a strategic perspective to her work.
Outside of work, she is a proud wife and mom of two, enjoying family time above all. With a keen interest in private investing, she applies the same thoughtful approach to both her professional and personal pursuits.
Board Caelen King Former Vice President of Product at NewBay Software, Caelen was a key member of the executive management team that revolutionized the Mobile Operator market with social mobile web applications. During his tenure, NewBay launched 5 product lines, built their user base to over 10 million and were deployed in 4 Continents with the largest and most prestigious mobile network operators. Before joining NewBay Software, Caelen led the marketing of Baltimore Technologies' (London:BLM) flagship product, UniCERT. Caelen had complete responsibility for formulating and delivering marketing strategies targeted at geographic and vertical markets. During this period UniCERT's software revenue grew from under $1million to in excess of $40m. While at Baltimore Technologies, Caelen was also responsible for the product management of new product lines. He is an avid rock-climber, as clinging for dear life to the side of a mountain is a relaxing break from being on the board of WhatClinic.
Maurice Roche Maurice Roche is a General Partner with Delta Partners having joined Delta in 1995. He has over 25 years experience of advising and investing in early stage technologies companies, 20 of those as a Venture Capitalist. Maurice serves as a non-executive director of a number of companies including Cleverbug, Digit Games Studios, Homestays, Hullomail, Tango Telecom, textHELP, WhatClinic.com and Zapa Technology. He was also previously a non-executive director of Xiam Technology Limited sold to Qualcomm (NASDAQ: QCOM), Pxit sold to Agilent (NYSE: A), O'Leary's (sold to Gehe, now Celesio Group) and Polarlake sold to Bloomberg. A graduate of University of Limerick in Business Studies, he holds a postgraduate degree from University College Dublin and is a Fellow of the Institute of Chartered Accountants in Ireland. He is a former Chairman of the Irish Venture Capital Association (July 2011 to June 2012). He was a member of the Research Prioritisation Project Steering Group which was chaired by Jim O’Hara (October 2010 to September 2011). This group was asked to make recommendations to Government on areas of focus for the next phase of Ireland’s science, technology and innovation strategy. The report was published by Forfas in March 2012.
Paddy Holahan Paddy Holahan is an experienced manager, technology entrepreneur and angel investor. In 2002 he founded NewBay which grew to become the leader in cloud digital lifestyle solutions for operators. NewBay’s customers included AT&T, T-Mobile, Telefonica/02, France Telecom/Orange, LG, Alltel and Telstra. NewBay was acquired by RIM(Blackberry) in October 2011 for a reported $100m. Prior to founding NewBay, Paddy was executive VP of Marketing and Product Management at Baltimore Technologies where he was instrumental growing Baltimore to become a public company valued at over $14bn. He was previously Chairman of Web Reservations International (Hostelworld.com) which was sold in 2009 for over €200m. Previous to this, Paddy was co-founder and CEO of East Coast Software. He has a first-class honours degree in Computer Science from Trinity College Dublin and completed the Leadership4Growth programme at Stanford University. He is also a Director of Asavie Ltd and Chairman of Homestay.com.
Paul McKeon Paul is an entrepreneur, investor and advisor to multiple technology Companies. His management experience ranges from advising small technology start-ups to being CEO of successful technology companies with an international bias. Paul McKeon is founder and former CEO of Propylon Limited. Paul is also a former director of Newbay Software Limited. Paul is currently Chairman of Propylon and a non-executive director with Newgame Technology T/A Swrve and the AMCS Group. Paul is the senior partner in Hogan & Associates Chartered Accountants and is a founder director of Mianach Venture Capital. Paul is a Fellow of the Institute of Chartered Accountants in Ireland.
Investors Caelen King (WhatClinic.com) and Maurice Roche (Delta Partners) Delta Delta Partners is a venture capital firm investing primarily in Ireland and the United Kingdom. It was established in 1994 and has €250 million under management. The firm has a strong focus on investing in early stage technology companies, and the team has made over 60 investments technology, medtech and healthcare businesses. Delta is among the most active early stage investors in Europe. The partners' backgrounds in operations, strategy and finance complement the drive and ambition of entrepreneurial management teams.
Enterprise Ireland Enterprise Ireland is the government organisation responsible for the development and growth of Irish enterprises in world markets. Enterprise Ireland works in partnership with Irish enterprises to help them start, grow, innovate and win export sales on global markets.
Mianach Venture Capital Mianach is one of Ireland's leading early stage, technology focused venture capital companies. Mianach aims to provide superior returns to investors in its fund by investing in, and helping entrepreneurs to grow, world class companies. Mianach specializes in investing in seed, start-up and early stage Irish technology businesses on the leading edge of new developments. Mianach invests in teams that can take proprietary technology and with the capital and support provided, build companies that become leaders in major world markets.
